Skip to main content
Drug bottle and Pill

Compare Epzicom vs. Baraclude

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Abacavir/lamivudine (Epzicom) and entecavir (Baraclude) are both nucleoside reverse transcriptase inhibitors (NRTIs) used to treat viral infections, but they target different viruses. Epzicom is used for HIV treatment when taken in combiantion with other HIV antiretrovirals, while Baraclude is used for hepatitis B. Epzicom is a combination medication taken as one tablet daily, whereas Baraclude is available as a tablet and a liquid solution, with dosing based on liver health and taken on an empty stomach. Epzicom is available as a generic, while only the tablet form of Baraclude has a generic version. Common side effects of Epzicom include headache and nausea, while Baraclude may cause headache and fatigue. Both medications carry risks of lactic acidosis and liver problems, but Epzicom also requires genetic testing for allergic reactions and is not recommended for those with heart issues. Baraclude is not ideal for people with both hepatitis B and HIV due to potential drug resistance.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.